Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Borderline Personality Disorder
NCT00204347Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jul 2003
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in borderline personality disorder (BPD), sponsored by University of Alabama at Birmingham. Started Jul 2003; status: completed.
02
Drugs
risperidone
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT00204347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204347.